Nisa Investment Advisors LLC Acquires 12,126 Shares of HCA Healthcare, Inc. $HCA

Nisa Investment Advisors LLC lifted its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 20.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 70,580 shares of the company’s stock after buying an additional 12,126 shares during the period. Nisa Investment Advisors LLC’s holdings in HCA Healthcare were worth $32,951,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Palisade Asset Management LLC bought a new position in HCA Healthcare during the third quarter valued at approximately $26,000. Holos Integrated Wealth LLC purchased a new stake in HCA Healthcare during the 4th quarter valued at $29,000. Harbor Capital Advisors Inc. boosted its stake in shares of HCA Healthcare by 82.9% in the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after buying an additional 34 shares during the last quarter. JPL Wealth Management LLC purchased a new stake in HCA Healthcare during the third quarter valued at $33,000. Finally, Aventura Private Wealth LLC purchased a new position in HCA Healthcare in the fourth quarter worth about $34,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Q4 earnings and guidance — HCA reported a sizeable EPS beat (reported $8.01 vs. $7.37 consensus), revenue rose ~6.7% year-over-year (slightly below sales estimates) and management set FY2026 EPS guidance of $29.10–$31.50, which supports a re-rating and underpins near-term investor optimism. Reflecting on hospital chains stocks Q4 earnings: HCA Healthcare (NYSE:HCA)
• Positive Sentiment: State approval for new Chesterfield hospital projects — Virginia’s commissioner approved HCA’s Chesterfield hospital developments after initial staff hesitation, clearing the way for expansion that can add bed capacity and local market share. VDH staff initially wanted to deny new Chesterfield HCA hospital. Why did the commissioner approve it?
• Positive Sentiment: Local leadership hires — HCA named a new CEO at TriStar StoneCrest Medical Center and announced C-suite appointments at other HCA hospitals (new CFO at HCA Houston Healthcare Tomball; COO at an HCA Florida hospital). These operational leadership moves reduce execution risk around expansions and can improve operational performance over time. HCA names new CEO for TriStar StoneCrest Medical Center HCA Houston Healthcare Tomball names new CFO HCA Florida hospital names COO
• Positive Sentiment: Community giving — TriStar (an HCA affiliate) announced a $40,000 grant to the American Cancer Society Hope Lodge (Nashville), a modest PR win that supports local reputation and community relationships. TriStar announces $40,000 grant for ACS Hope Lodge in Nashville
• Neutral Sentiment: New emergency transport services — coverage of AirLife expanding timely emergency care is sector-positive for patient outcomes and throughput but has no direct, immediate financial read-through to HCA. AirLife takes flight, helping patients get timely emergency care
• Neutral Sentiment: Regulatory process color — reporting that VDH staff originally recommended denying the Chesterfield project highlights lingering regulatory scrutiny in certain markets; approval is positive but the back-and-forth indicates project risk exists. VDH staff first said no to new Chesterfield hospital. Why commissioner said yes.
• Negative Sentiment: Legislative/regulatory risk — Rep. Edwards is pushing a bill to give CMS authority to “take over” Mission Hospital, signaling heightened federal oversight and potential political/regulatory intervention for hospitals; investors may price increased compliance risk and operational uncertainty into shares. Rep. Edwards wants to give CMS ability to ‘take over’ Mission Hospital

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction that occurred on Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the transaction, the senior vice president directly owned 11,993 shares of the company’s stock, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Michael S. Cuffe sold 1,500 shares of HCA Healthcare stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the completion of the sale, the executive vice president directly owned 30,003 shares in the company, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 15,214 shares of company stock valued at $7,797,595. 1.50% of the stock is currently owned by insiders.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $472.68 on Wednesday. The stock has a fifty day simple moving average of $510.83 and a two-hundred day simple moving average of $477.48. HCA Healthcare, Inc. has a 52-week low of $314.43 and a 52-week high of $556.52. The firm has a market capitalization of $105.68 billion, a PE ratio of 16.66, a PEG ratio of 1.44 and a beta of 1.34.

HCA Healthcare (NYSE:HCA) last released its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter last year, the business posted $6.22 earnings per share. The firm’s revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, sell-side analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th were given a dividend of $0.78 per share. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Tuesday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.99%.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on the stock. TD Cowen raised their price objective on shares of HCA Healthcare from $529.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, March 10th. Truist Financial lifted their price target on shares of HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Barclays raised their target price on HCA Healthcare from $494.00 to $551.00 and gave the stock an “overweight” rating in a report on Wednesday, January 28th. KeyCorp set a $503.00 price target on HCA Healthcare in a report on Wednesday, January 28th. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Sixteen investment analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $537.73.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.